Winston & Strawn LLP has advised Neuphoria Therapeutics Inc. Mintz has advised the placement agents (Leerink Partners, TD Cowen, H.C. Wainwright & Co.) in connection with...
Scancell and Neuphoria Announce $250 Million All-Share Merger and $89 Million Financing
MoonLake Immunotherapeutics Completes $200 Million Public Offering of Class A Shares
Gibson, Dunn & Crutcher LLP and Walkers (Cayman) LLP have advised MoonLake Immunotherapeutics. Mintz has advised the underwriters. MoonLake Immunotherapeutics (NASDAQ: MLTX) has completed a public...
Assembly Biosciences Completes $115 Million Registered Offering of Common Stock and Pre-Funded Warrants
Skadden has advised Assembly Biosciences. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo has advised the underwriters. Assembly Biosciences, Inc. has announced the closing of its underwritten...
InflaRx Prices $150 Million Public Offering of Ordinary Shares
Kirkland & Ellis has advised InflaRx. Mintz has advised the underwriters. InflaRx N.V., a biopharmaceutical company focused on anti-inflammatory therapeutics, has announced the pricing of its...
Celldex Therapeutics Raises $345 Million in Public Offering of Common Stock
Lowenstein Sandler LLP has advised Celldex Therapeutics, Inc., and Wilmer Cutler Pickering Hale and Dorr has represented the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) has announced...
Western Copper and Gold Completes $92 Million Public Offering
Cassels has advised Western Copper and Gold Corporation. Miller Thomson and Skadden have advised the underwriters. Western Copper and Gold Corporation completed a bought deal public...
Ondas Holdings Completes $1 Billion Equity Offering
Akerman LLP has advised Ondas Holdings Inc. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has represented the placement agents. Snell & Wilmer LLP acted as...
Protara Therapeutics Prices $75 Million Public Offering
Kirkland & Ellis LLP has advised Protara Therapeutics, Inc. Mintz has advised the underwriters. Protara Therapeutics, Inc., a clinical-stage company focused on transformative therapies for cancer...
Capricor Therapeutics Completes $172.5 Million Public Offering of Common Stock
Sidley Austin has advised Capricor Therapeutics. Mintz has advised the underwriters. Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company, has completed an underwritten public offering of...
Belite Bio Prices $350 Million Public Offering of American Depositary Shares
O’Melveny & Myers LLP and Maples and Calder (Hong Kong) LLP have advised Belite Bio. Wilson Sonsini Goodrich & Rosati has advised Belite Bio on patent...
Verastem Oncology Prices $90 Million Public Offering
Ropes & Gray has advised Verastem Oncology. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. has advised the underwriters. Verastem Oncology (Nasdaq: VSTM) has announced the...
Access Industries Completes Secondary Offering of Disc Medicine Shares
Debevoise & Plimpton LLP has advised Access Industries. Goodwin Procter LLP and White & Case LLP, along with Wolf, Greenfield & Sacks, P.C., have advised Disc...